Global Alzheimer’s Drug Market: Trends, Opportunities and Forecasts (2015-2020) (By Type - Imaging, Therapeutics, Diagnostics, Biomarkers; By Age: <65 years, >65 years age; By Region; Global Dementia Market)
Table of Contents
1. Research Methodology
2. Alzheimer’s Disease Market Overview
3. Global Alzheimer’s Disease Market Outlook
4. Global Alzheimer’s Disease Market
4.1 By Therapeutics
4.2 By Diagnostics and Biomarkers
4.3 By Imaging Sector
4.4 By Disease Modifying Therapeutics
5. Global Alzheimer’s Disease Market Outlook-By Demographic (Age-Group)
6. Global Alzheimer’s Disease Market Outlook-By Drug
7. Global Alzheimer’s Disease Market Outlook-By Region
8. United States Alzheimer’s Disease Market Outlook
8.1 United States Dementia Market Outlook
9. Global Dementia Disease Market Outlook
10. Global Dementia Disease Market Outlook
10.1 By Regional Break-Up
10.1.1 Asia-Pacific Dementia Market Outlook
10.2 By Countries
10.2.1 Low Income Country -wise Break up
10.2.2 Top Ten Country-wise Break-Up
Australia Dementia Market Outlook
UK Dementia Market Outlook
11. Market Dynamics
11.1 Drivers
11.2 Challenges
12. Market Trends & Developments
13. Competitive Landscape
13.1 Sales Comparatives, Top 5 Companies
13.2 EBITDA Comparatives, Top 5 Companies
13.3 EBIT Comparatives, Top 5 Companies
13.4 PBT Comparatives, Top 5 Companies
13.5 PAT Comparatives, Top 5 Companies
13.6 Current Ratio Comparatives, Top 5 Companies
14. Company Profiling
14.1 Pfizer Inc.
14.2 Novartis International AG
14.3 Axovant Sciences Ltd.
14.4 Acadia Pharmaceuticals
14.5 Biotie Therapies
List of Figures
1. Global Alzheimer’s Disease Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
2. Global Alzheimer’s Disease Market by Therapeutics ,By Value (USD Million) 2010-2020F
3. Global Alzheimer’s Market share, By Therapeutics
4. Global Alzheimer’s Disease Market , By Diagnostics and Biomarkers ,By Value (USD Billion)
5. Global Alzheimer’s Disease Market, By Imaging Sector, By Value (USD Million)
6. Global Alzheimer’s Disease Market by Disease Modifying Therapeutics Market Size ,By Value (USD Million)
7. Global Alzheimer’s Disease Market, By Demographics, By Age < 65, By Volume (Number of patients in million),2010-2020F
8. Global Alzheimer’s Disease Market, By Demographics, By Age > 65, By Volume (Number of patients in million),2010-2020F
9. Global Memantine (Nameda) Drug Market Size ,By Value (USD Billion) and Volume (Number of Patients in Million) 2010-2020F
10. United States Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
11. Cost of Alzheimer Disease in United States, By Payer, By percentage, 2010-14
12. U.S. Alzheimer’s Drug RTV-101 Market , By Value & Penetration Rate; 2019-2027 (USD Million)
13. U.S. Alzheimer’s Drug Azeliragon Market, By Value & Penetration Rate, 2019-2027 (USD Million)
14. U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
15. U.S. Annual Alzheimer’s Death Rates ,By Age; 2006-2013
16. Global Dementia Disease Market Size ,By Value (USD Million) and Volume (Number of Patients In Million) 2010-2020F
17. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
18. Global Dementia Disease Market Size , By Number of new cases, By Volume (Number of Patients In Million), By Region 2014
19. Asia-Pacific Dementia Disease Market Size , By Volume (Number of Patients In Million), By country 2015E,2030F,2050F
20. Global Dementia Disease Market Size , By Volume (Number of Patients In Million), By Region 2014
21. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
22. Global Dementia Disease Market Size Low Income Countries ,Volume (Number of Patients In Million) 2010-2020F
23. Global Dementia Disease Market Size in Top Ten Countries ,Volume (Number of Patients In Million) 2010-2020F
24. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
25. Australia Dementia Disease Market Size , By Volume (Number of Patients In Million) 2010-2020F
26. UK Dementia Market, By Type, 2014 (%)
27. UK Dementia Cost, By Type of Service, 2014 (%)
28. Number of Unpaid Caregivers (In Million)
29. Pfizer Revenue (USD Million) AY 2011-2014
30. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
31. Pfizer Percentage Revenue, By Business Segment (2014)
32. Pfizer Percentage Revenue, By Geography (2014)
33. Novartis International AG Revenue (USD Million) AY 2011-2014
34. Novartis International AG Percentage Revenue, By Business Segment (2014)
35. Novartis International AG Percentage Revenue, By Geography (2014)
36. Axovant Services Ltd. Revenue (USD Million) FY 2011-2015
37. Axovant Services Ltd. Percentage Revenue, By Business Segment (2014)
38. Axovant Services Ltd. Percentage Revenue, By Geography (2014)
39. Acadia Pharmaceuticals Revenue (USD Million) AY 2011-2014
40. Acadia Pharmaceuticals Percentage Revenue, By Business Segment (2014)
41. Acadia Pharmaceuticals Percentage Revenue, By Geography (2014)
42. Biotie Therapies Revenue (USD Million) AY 2011-2014
43. Biotie Therapies Percentage Revenue, By Business Segment (2014)
44. Sales Comparatives, Top 5 Companies, 2011-2014
45. EBITDA Comparatives, Top 5 Companies, 2011-2015
46. EBIT Comparatives, Top 5 Companies, 2011-2015
47. PBT Comparatives, Top 5 Companies, 2011-2015
48. PAT Comparatives, Top 5 Companies, 2011-2015
49. Current Ratio Comparatives, Top 5 Companies, 2011-2015
50. Profit Margin Ratio Comparatives, Top 5 Companies, 2011-2015
51. Debt Equity Ratio Comparatives, Top 5 Companies, 2011-2015
Global Alzheimer's Disease Drug Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 93
According to our LPI (LP Information) latest study, the global Alzheimer's Disease Drug market size was valued at US$ 3539.3 million in 2023. With growing demand in downstream market, the Alzheimer's Disease Drug is forecast to a readjusted size of US$ 3943.3 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Alzheimer's Disease Drug market. Alzheimer's Disease Drug are expected to show stable growth in the future m......
Alzheimer's Drugs - Global Market Insights and Sales Trends 2024
Published: 25-Dec-2023 Price: US 3350 Onwards Pages: 97
The global Alzheimer's Drugs market size is expected to reach US$ million by 2029, growing at a CAGR of % from 2023 to 2029. The market is mainly driven by the significant applications of Alzheimer's Drugs in various end use industries. The expanding demands from the Under 65 Years Old and 65 and Above 65 Years Old, are propelling Alzheimer's Drugs market. Acetylcholinesterase (AChE) Inhibitors, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by t......
Alzheimer Disease Drugs Industry Forecasts - China Focus
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 111
This study focuses on China's Alzheimer Disease Drugs industry forecasts. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumptions of goods and servi......
Alzheimer Disease Drugs Companies in China
Published: 27-Nov-2023 Price: US 1800 Onwards Pages: 74
This study focuses on China's Alzheimer Disease Drugs industry assessments and company profiles. In the two past decades, the industry has been growing at a fast pace. The dramatic expansions of the manufacturing capabilities and rising consumer consumptions in China have transformed China's society and economy. China is one of the world's major producers for industrial and consumer products. Far outpacing other economies in the world, China is the world's fastest growing market for the consumpt......
Alzheimer Disease Drugs Markets in China
Published: 27-Nov-2023 Price: US 4000 Onwards Pages: 239
China's demand for Alzheimer Disease Drugs has grown at a fast pace in the past decade. In the next decade, both production and demand will continue to grow. The Chinese economy maintains a high speed growth which has been stimulated by the consecutive increases of industrial output, imports & exports, consumer consumption and capital investment for over two decades. This new study examines China's economic trends, investment environment, industry development, supply and demand, industry capacit......
Global Alzheimer's Disease Drug Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2028
Published: 12-Sep-2023 Price: US 3380 Onwards Pages: 117
Market Overview of Global Alzheimer's Disease Drug market:
According to our latest research, the global Alzheimer's Disease Drug market looks promising in the next 5 years. As of 2022, the global Alzheimer's Disease Drug market was estimated at USD XX million, and it's anticipated to reach USD XX million in 2028, with a CAGR of XX% during the forecast years.
Alzheimer's disease is an irreversible, progressive brain disorder that slowly destroys memory and thinking skills and,......
Global Dementia and Movement Disorder Treatment Market Insights, Forecast to 2029
Published: 11-Aug-2023 Price: US 4900 Onwards Pages: 110
Dementia is a collective term for disorders characterized by progressive degeneration of the brain. It impairs memory and affects behavioral, emotional, and cognitive abilities. The neuronal death or neuronal malfunction associated with the disorder manifests as shifts in mood and personality changes, difficulty in performing activities, loss of memory, and aphasia.
Market Analysis and Insights: Global Dementia and Movement Disorder Treatment Market
The global Dementia and Movement......
Global Nicergoline Market Insights, Forecast to 2029
Published: 04-Jul-2023 Price: US 4900 Onwards Pages: 112
The global Nicergoline market is projected to grow from US$ million in 2023 to US$ million by 2029, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.
The US & Canada market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
The China market for Nicergoline is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR......
Global Oxiracetam Market Research Report 2023
Published: 21-Apr-2023 Price: US 2900 Onwards Pages: 69
Highlights
The global Oxiracetam market was valued at US$ million in 2022 and is anticipated to reach US$ million by 2029, witnessing a CAGR of % during the forecast period 2023-2029. The influence of COVID-19 and the Netherlands-Ukraine War were considered while estimating market sizes.
North American market for Oxiracetam is estimated to increase from $ million in 2023 to reach $ million by 2029, at a CAGR of % during the forecast period of 2023 through 2029.
Asia-Pacific ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs